Clinical Management of Brugada Syndrome: Commentary From the Experts
Michael J. Cutler, Lee L. Eckhardt, Elizabeth S. Kaufman, Elena Arbelo, Elijah R. Behr, Pedro Brugada, Marina Cerrone, Lia Crotti, Carlo de Asmundis, Michael H. Gollob, Minoru Horie, David T. Huang, Andrew D. Krahn, Barry London, Steven A. Lubitz, Judith A. Mackall, Koonlawee Nademanee, Marco Pérez, Vincent Probst, Dan M. Roden, Frédéric Sacher, Georgia Sarquella‐Brugada, Melvin M. Scheinman, Wataru Shimizu, Benjamin Shoemaker, Raymond W. Sy, Atsuyuki Watanabe, Arthur A.M. Wilde
Abstract
Although there is consensus on the management of patients with Brugada Syndrome with high risk for sudden cardiac arrest, asymptomatic or intermediate-risk patients present clinical management challenges. This document explores the management opinions of experts throughout the world for patients with Brugada Syndrome who do not fit guideline recommendations. Four real-world clinical scenarios were presented with commentary from small expert groups for each case. All authors voted on case-specific questions to evaluate the level of consensus among the entire group in nuanced diagnostic and management decisions relevant to each case. Points of agreement, points of controversy, and gaps in knowledge are highlighted.